Electrophysiologic effects isoproterenol patients atrioventricular reentrant tachycardia flecainide electrophysiologic effects isoproterenol patients flecainide atrioventricular AV tachycardia mechanism tachycardia inducibility isoproterenol value isoproterenol challenge predictor spontaneous arrhythmia recurrence Seventeen patients underwent electrophysiologic study oral flecainide administration addition isoproterenol patient inducible supraventricular tachycardia flecainide patients inducible inducible nonsustained tachycardia isoproterenol patients flecainide dose time electrophysiologic study Findings Flecainide treatment HV VA intervals addition isoproterenol variables Isoproterenol anterograde block cycle length refractory period accessory pathway AV node tachycardia cycle length effect due AV conduction time Flecainide treatment tachycardia induction retrograde conduction accessory pathway Isoproterenol tachycardia induction sustained episodes tachycardia effect flecainide retrograde accessory pathway conduction Tachycardia follow-up patients tachycardia equal duration isoproterenol patient episodes induced tachycardia change medical regimen Conclusions Isoproterenol flecainide-induced prolongation block cycle length refractory periods accessory pathway AV node Isoproterenol flecainide-induced prevention tachycardia induction reversal effects flecainide retrograde accessory pathway addition isoproterenol flecainide restudy valuable long-term drug efficacy 